Sotera Health Q4 2023 Earnings Report
Key Takeaways
Sotera Health's Q4 2023 net revenues increased by 23.3% to $310 million compared to the same period last year. Net income was $39 million, a significant improvement from the net loss of $320 million in Q4 2022. Adjusted EBITDA increased by 28.7% to $167 million, and Adjusted EPS was $0.26, up by $0.01 per diluted share.
Net revenues for Q4 2023 increased by 23.3% to $310 million.
Net income for Q4 2023 was $39 million, compared to a net loss of $320 million in Q4 2022.
Adjusted EBITDA for Q4 2023 increased by 28.7% to $167 million.
Adjusted EPS for Q4 2023 was $0.26, an increase of $0.01 per diluted share.
Sotera Health
Sotera Health
Sotera Health Revenue by Segment
Forward Guidance
Sotera Health is providing its full-year 2024 outlook with net revenues and Adjusted EBITDA growth in the range of 4.0% to 6.0%.
Positive Outlook
- Net revenues growth in the range of 4.0% to 6.0%.
- Adjusted EBITDA growth in the range of 4.0% to 6.0%.
- Tax rate applicable to Adjusted Net Income in the range of 31.5% to 34.5%.
- Adjusted EPS in the range of $0.67 to $0.75.
- Capital expenditures in the range of $205 million to $225 million.
Challenges Ahead
- Interest Expense in the range of $170 million to $180 million.
- Uncertainties caused by changes to the regulatory landscape.
- Restructuring items.
- Certain fair value measurements.
- Impact of inflationary trends including their impact on energy prices and the supply of labor.
Revenue & Expenses
Visualization of income flow from segment revenue to net income